| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.825 | 0.004 | 0.825 | Aldehyde oxidase inhibitor | 0.733 0.006 DBMET00100 0.553 0.025 DBMET00101 0.269 0.076 DBMET00102 0.161 0.13 DBMET03597 | ||
| 0.658 | 0.004 | 0.658 | Dopamine D4 antagonist | 0.369 0.005 DBMET00100 0.263 0.009 DBMET00101 | ||
| 0.572 | 0.011 | 0.572 | GABA C receptor rho-3 antagonist | 0.547 0.015 DBMET00100 0.437 0.046 DBMET00101 | ||
| 0.529 | 0.002 | 0.529 | 5 Hydroxytryptamine 3B antagonist | 0.311 0.003 DBMET00100 0.087 0.006 DBMET00101 | ||
| 0.541 | 0.018 | 0.551 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.551 0.016 DBMET00100 0.441 0.068 DBMET00101 0.344 0.157 DBMET00102 0.377 0.122 DBMET03597 | DBMET00100 | |
| 0.508 | 0.026 | 0.518 | 5 Hydroxytryptamine release stimulant | 0.518 0.024 DBMET00100 0.214 0.11 DBMET00101 | DBMET00100 | |
| 0.482 | 0.007 | 0.526 | 5 Hydroxytryptamine 2 antagonist | 0.402 0.01 DBMET00100 0.526 0.005 DBMET00101 | DBMET00101 | |
| 0.478 | 0.008 | 0.478 | 5 Hydroxytryptamine antagonist | 0.356 0.014 DBMET00100 0.41 0.011 DBMET00101 | ||
| 0.481 | 0.023 | 0.491 | MAP kinase kinase 6 inhibitor | 0.491 0.02 DBMET00100 0.395 0.062 DBMET00101 0.426 0.044 DBMET00102 0.435 0.04 DBMET03597 | DBMET00100 | |
| 0.456 | 0.003 | 0.456 | 5 Hydroxytryptamine 3 antagonist | 0.324 0.004 DBMET00100 0.269 0.004 DBMET00101 | ||
| 0.459 | 0.012 | 0.459 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.453 0.013 DBMET00100 0.32 0.051 DBMET00101 0.373 0.028 DBMET00102 0.375 0.027 DBMET03597 | ||
| 0.445 | 0.004 | 0.445 | 5 Hydroxytryptamine 1E antagonist | 0.37 0.007 DBMET00100 0.306 0.026 DBMET00101 | ||
| 0.439 | 0.002 | 0.439 | Histamine H4 receptor antagonist | 0.308 0.002 DBMET00100 0.1 0.005 DBMET00101 | ||
| 0.441 | 0.006 | 0.448 | 5 Hydroxytryptamine 2A antagonist | 0.352 0.009 DBMET00100 0.448 0.005 DBMET00101 | DBMET00101 | |
| 0.435 | 0.007 | 0.497 | 5 Hydroxytryptamine 2B antagonist | 0.364 0.01 DBMET00100 0.497 0.005 DBMET00101 | DBMET00101 | |
| 0.431 | 0.004 | 0.431 | Toll-Like receptor 9 antagonist | 0.359 0.006 DBMET00100 0.181 0.045 DBMET00101 | ||
| 0.426 | 0.004 | 0.504 | Dopamine D1 antagonist | 0.261 0.007 DBMET00100 0.504 0.003 DBMET00101 | DBMET00101 | |
| 0.419 | 0.019 | 0.419 | Anticonvulsant | 0.314 0.037 DBMET00100 0.349 0.029 DBMET00102 0.268 0.05 DBMET03597 | ||
| 0.404 | 0.008 | 0.425 | Dopamine antagonist | 0.248 0.015 DBMET00100 0.425 0.007 DBMET00101 | DBMET00101 | |
| 0.384 | 0.006 | 0.384 | 5 Hydroxytryptamine 2C antagonist | 0.321 0.008 DBMET00100 0.186 0.019 DBMET00101 | ||
| 0.384 | 0.018 | 0.384 | ErbB-1 antagonist | 0.319 0.028 DBMET00100 0.246 0.053 DBMET00101 | ||
| 0.382 | 0.019 | 0.565 | Cyclic AMP phosphodiesterase inhibitor | 0.359 0.024 DBMET00100 0.159 0.137 DBMET00101 0.565 0.005 DBMET00102 0.562 0.005 DBMET03597 | DBMET00102 | |
| 0.363 | 0.005 | 0.363 | Alpha 2b adrenoreceptor antagonist | 0.322 0.008 DBMET00100 0.313 0.008 DBMET00101 | ||
| 0.361 | 0.005 | 0.361 | 5 Hydroxytryptamine 1F antagonist | 0.308 0.005 DBMET00100 0.095 0.034 DBMET00101 | ||
| 0.355 | 0.004 | 0.355 | Protein kinase C zeta inhibitor | 0.305 0.005 DBMET00100 0.111 0.039 DBMET00101 0.197 0.011 DBMET00102 0.184 0.013 DBMET03597 | ||
| 0.417 | 0.067 | 0.417 | Histamine release inhibitor | 0.34 0.105 DBMET00100 0.351 0.099 DBMET00102 0.254 0.152 DBMET03597 | ||
| 0.351 | 0.005 | 0.351 | Alpha 2a adrenoreceptor antagonist | 0.31 0.006 DBMET00100 0.229 0.011 DBMET00101 | ||
| 0.334 | 0.005 | 0.334 | Toll-Like receptor antagonist | 0.293 0.008 DBMET00100 | ||
| 0.326 | 0.004 | 0.326 | Alpha 1 adrenoreceptor agonist | 0.268 0.005 DBMET00100 0.055 0.043 DBMET00101 | ||
| 0.317 | 0.003 | 0.317 | 5 Hydroxytryptamine 3 agonist | 0.247 0.003 DBMET00100 0.099 0.016 DBMET00101 | ||
| 0.322 | 0.009 | 0.373 | Dopamine D2 antagonist | 0.203 0.017 DBMET00100 0.373 0.008 DBMET00101 | DBMET00101 | |
| 0.321 | 0.014 | 0.401 | Alpha adrenoreceptor antagonist | 0.277 0.017 DBMET00100 0.401 0.009 DBMET00101 | DBMET00101 | |
| 0.301 | 0.004 | 0.31 | 5 Hydroxytryptamine 3A agonist | 0.31 0.003 DBMET00100 0.18 0.022 DBMET00101 | DBMET00100 | |
| 0.295 | 0.012 | 0.323 | Ribosomal protein S6 kinase inhibitor | 0.323 0.009 DBMET00100 0.179 0.047 DBMET00101 0.194 0.039 DBMET00102 0.21 0.033 DBMET03597 | DBMET00100 | |
| 0.319 | 0.038 | 0.319 | Psychostimulant | 0.31 0.04 DBMET00100 0.136 0.13 DBMET00101 0.307 0.041 DBMET00102 0.316 0.039 DBMET03597 | ||
| 0.28 | 0.004 | 0.28 | Benzodiazepine agonist | 0.187 0.005 DBMET00100 0.137 0.01 DBMET00101 | ||
| 0.305 | 0.029 | 0.305 | Gastrin inhibitor | 0.234 0.099 DBMET00100 | ||
| 0.299 | 0.025 | 0.312 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.312 0.02 DBMET00100 0.237 0.083 DBMET00101 0.288 0.032 DBMET00102 0.302 0.024 DBMET03597 | DBMET00100 | |
| 0.273 | 0.003 | 0.273 | 5 Hydroxytryptamine 3A antagonist | 0.202 0.004 DBMET00100 0.085 0.026 DBMET00101 | ||
| 0.282 | 0.012 | 0.411 | Alpha 1 adrenoreceptor antagonist | 0.258 0.014 DBMET00100 0.411 0.006 DBMET00101 | DBMET00101 | |
| 0.27 | 0.009 | 0.396 | Alpha 1b adrenoreceptor antagonist | 0.229 0.012 DBMET00100 0.396 0.005 DBMET00101 | DBMET00101 | |
| 0.271 | 0.011 | 0.271 | Alpha 1a adrenoreceptor antagonist | 0.256 0.012 DBMET00100 0.187 0.018 DBMET00101 | ||
| 0.258 | 0.005 | 0.258 | Platelet growth factor antagonist | 0.215 0.008 DBMET00100 0.138 0.023 DBMET00101 0.088 0.05 DBMET00102 | ||
| 0.279 | 0.026 | 0.279 | LIM domain kinase 1 inhibitor | 0.274 0.028 DBMET00100 0.135 0.114 DBMET00101 | ||
| 0.261 | 0.01 | 0.261 | Alpha 2 adrenoreceptor antagonist | 0.236 0.013 DBMET00100 0.153 0.026 DBMET00101 | ||
| 0.308 | 0.059 | 0.308 | Aryl hydrocarbon receptor agonist | 0.273 0.07 DBMET00100 0.164 0.125 DBMET00101 | ||
| 0.288 | 0.039 | 0.288 | MAP kinase kinase 2 inhibitor | 0.262 0.049 DBMET00100 | ||
| 0.286 | 0.038 | 0.29 | MAP-kinase-activated kinase 5 inhibitor | 0.29 0.036 DBMET00100 0.163 0.161 DBMET00101 0.18 0.132 DBMET00102 0.19 0.117 DBMET03597 | DBMET00100 | |
| 0.287 | 0.04 | 0.287 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.238 0.055 DBMET00100 | ||
| 0.247 | 0.006 | 0.251 | Alpha adrenoreceptor agonist | 0.251 0.005 DBMET00100 | DBMET00100 | |
| 0.259 | 0.019 | 0.259 | Activin receptor-like kinase 2 inhibitor | 0.256 0.019 DBMET00100 | ||
| 0.286 | 0.047 | 0.296 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.296 0.044 DBMET00100 0.161 0.103 DBMET00102 0.175 0.092 DBMET03597 | DBMET00100 | |
| 0.255 | 0.016 | 0.282 | Platelet activating factor beta antagonist | 0.202 0.024 DBMET00100 0.282 0.013 DBMET00101 | DBMET00101 | |
| 0.369 | 0.131 | 0.456 | Caspase 9 stimulant | 0.456 0.08 DBMET00100 0.361 0.137 DBMET00102 0.433 0.092 DBMET03597 | DBMET00100 | |
| 0.258 | 0.023 | 0.298 | Acetylcholine M1 receptor antagonist | 0.191 0.047 DBMET00100 0.298 0.015 DBMET00101 0.181 0.051 DBMET00102 0.125 0.101 DBMET03597 | DBMET00101 | |
| 0.241 | 0.008 | 0.241 | Dopamine D3 antagonist | 0.139 0.017 DBMET00100 0.124 0.019 DBMET00101 | ||
| 0.277 | 0.044 | 0.277 | EphB2 antagonist | 0.24 0.062 DBMET00100 | ||
| 0.271 | 0.04 | 0.271 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.208 0.06 DBMET00100 | ||
| 0.241 | 0.01 | 0.336 | Histamine H1 receptor antagonist | 0.147 0.025 DBMET00100 0.336 0.005 DBMET00101 | DBMET00101 | |
| 0.259 | 0.033 | 0.259 | I kappa B kinase epsilon inhibitor | 0.252 0.037 DBMET00100 | ||
| 0.28 | 0.055 | 0.28 | HERG channel blocker | 0.273 0.057 DBMET00100 | ||
| 0.288 | 0.072 | 0.45 | Hypoxia-inducible factor 1 alpha inhibitor | 0.3 0.066 DBMET00100 0.45 0.02 DBMET00102 0.439 0.022 DBMET03597 | DBMET00102 | |
| 0.22 | 0.005 | 0.29 | GABA A receptor antagonist | 0.29 0.004 DBMET00100 0.062 0.029 DBMET00101 | DBMET00100 | |
| 0.224 | 0.01 | 0.224 | Potassium channel (Ca-activated) activator | 0.199 0.015 DBMET00100 0.1 0.056 DBMET00101 | ||
| 0.254 | 0.042 | 0.254 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.242 0.046 DBMET00100 | ||
| 0.217 | 0.005 | 0.295 | GABA receptor antagonist | 0.295 0.004 DBMET00100 0.06 0.032 DBMET00101 | DBMET00100 | |
| 0.214 | 0.003 | 0.214 | Potassium channel small-conductance Ca-activated blocker | 0.151 0.004 DBMET00100 0.075 0.011 DBMET00101 | ||
| 0.3 | 0.092 | 0.377 | Calcium channel activator | 0.377 0.034 DBMET00100 0.206 0.204 DBMET00101 0.25 0.147 DBMET03597 | DBMET00100 | |
| 0.21 | 0.008 | 0.21 | 5 Hydroxytryptamine 1B antagonist | 0.13 0.015 DBMET00100 | ||
| 0.22 | 0.023 | 0.236 | Death-associated protein kinase 2 inhibitor | 0.236 0.017 DBMET00100 0.198 0.036 DBMET00101 0.141 0.128 DBMET03597 | DBMET00100 | |
| 0.254 | 0.058 | 0.254 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.232 0.07 DBMET00100 0.209 0.084 DBMET00102 0.202 0.089 DBMET03597 | ||
| 0.21 | 0.015 | 0.428 | GABA receptor agonist | 0.187 0.021 DBMET00100 0.428 0.004 DBMET00101 | DBMET00101 | |
| 0.206 | 0.014 | 0.206 | Insulin receptor antagonist | 0.139 0.032 DBMET00100 | ||
| 0.201 | 0.012 | 0.358 | Protein kinase C mu inhibitor | 0.266 0.006 DBMET00100 0.103 0.054 DBMET00101 0.331 0.004 DBMET00102 0.358 0.004 DBMET03597 | DBMET03597 | |
| 0.254 | 0.065 | 0.254 | Potassium channel blocker | 0.24 0.071 DBMET00100 | ||
| 0.195 | 0.006 | 0.313 | Acetylcholine M4 receptor antagonist | 0.141 0.012 DBMET00100 0.313 0.004 DBMET00101 | DBMET00101 | |
| 0.205 | 0.017 | 0.205 | Alpha 2c adrenoreceptor antagonist | 0.17 0.025 DBMET00100 0.165 0.026 DBMET00101 | ||
| 0.204 | 0.016 | 0.272 | Check point kinase 2 inhibitor | 0.272 0.008 DBMET00100 0.134 0.039 DBMET00101 | DBMET00100 | |
| 0.252 | 0.066 | 0.252 | Tyrosine 3 hydroxylase inhibitor | 0.247 0.071 DBMET00100 0.206 0.125 DBMET00101 | ||
| 0.207 | 0.032 | 0.207 | NADPH oxidase inhibitor | 0.19 0.038 DBMET00100 | ||
| 0.189 | 0.017 | 0.189 | Protein kinase C gamma inhibitor | 0.165 0.024 DBMET00100 0.096 0.084 DBMET00102 0.097 0.083 DBMET03597 | ||
| 0.192 | 0.023 | 0.192 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.178 0.034 DBMET00100 0.145 0.083 DBMET00101 0.158 0.059 DBMET00102 0.153 0.068 DBMET03597 | ||
| 0.176 | 0.012 | 0.176 | Alpha 1d adrenoreceptor antagonist | 0.155 0.014 DBMET00100 0.121 0.019 DBMET00101 | ||
| 0.194 | 0.033 | 0.194 | GABA C receptor rho-2 antagonist | 0.189 0.036 DBMET00100 0.132 0.102 DBMET00101 | ||
| 0.176 | 0.015 | 0.179 | Hedgehog signaling inhibitor | 0.179 0.015 DBMET00100 | DBMET00100 | |
| 0.19 | 0.029 | 0.218 | Glutamate receptor antagonist | 0.218 0.021 DBMET00100 | DBMET00100 | |
| 0.175 | 0.015 | 0.175 | ALK inhibitor | 0.172 0.015 DBMET00100 | ||
| 0.309 | 0.15 | 0.352 | Calcium channel L-type activator | 0.352 0.116 DBMET00100 0.288 0.168 DBMET00101 | DBMET00100 | |
| 0.164 | 0.005 | 0.164 | 5 Hydroxytryptamine 6 antagonist | 0.148 0.006 DBMET00100 0.05 0.049 DBMET00101 | ||
| 0.178 | 0.02 | 0.178 | Pregnane X receptor agonist | 0.164 0.033 DBMET00100 0.127 0.107 DBMET00101 | ||
| 0.17 | 0.016 | 0.17 | 5 Hydroxytryptamine 7 antagonist | 0.151 0.018 DBMET00100 | ||
| 0.173 | 0.02 | 0.173 | 5 Hydroxytryptamine 1 antagonist | 0.114 0.032 DBMET00100 0.063 0.06 DBMET00101 | ||
| 0.157 | 0.007 | 0.157 | Bromodomain-containing protein 2 inhibitor | 0.144 0.011 DBMET00100 | ||
| 0.199 | 0.05 | 0.199 | Antipruritic | 0.175 0.069 DBMET00100 | ||
| 0.16 | 0.012 | 0.185 | Cyclin B3 inhibitor | 0.185 0.008 DBMET00100 0.079 0.039 DBMET00101 | DBMET00100 | |
| 0.173 | 0.026 | 0.173 | Antihistaminic | 0.105 0.051 DBMET00100 0.171 0.027 DBMET00101 | ||
| 0.225 | 0.08 | 0.225 | Potassium channel (Voltage-sensitive) blocker | 0.215 0.085 DBMET00100 | ||
| 0.238 | 0.093 | 0.238 | 5 Hydroxytryptamine uptake stimulant | 0.223 0.113 DBMET00100 | ||
| 0.158 | 0.019 | 0.158 | 5 Hydroxytryptamine 1A antagonist | 0.118 0.026 DBMET00100 0.068 0.047 DBMET00101 | ||
| 0.143 | 0.005 | 0.143 | Histamine agonist | 0.102 0.009 DBMET00100 | ||
| 0.163 | 0.026 | 0.163 | Histamine antagonist | 0.095 0.051 DBMET00100 0.163 0.026 DBMET00101 | ||
| 0.145 | 0.008 | 0.192 | Acetylcholine M5 receptor antagonist | 0.094 0.019 DBMET00100 0.192 0.005 DBMET00101 | DBMET00101 | |
| 0.138 | 0.006 | 0.191 | 5 Hydroxytryptamine 2A agonist | 0.191 0.004 DBMET00100 | DBMET00100 | |
| 0.198 | 0.067 | 0.201 | 5 Hydroxytryptamine 3E antagonist | 0.201 0.061 DBMET00100 | DBMET00100 | |
| 0.2 | 0.07 | 0.2 | Focal adhesion kinase 2 inhibitor | 0.2 0.069 DBMET00100 | ||
| 0.143 | 0.013 | 0.143 | 5 Hydroxytryptamine 1D antagonist | 0.085 0.028 DBMET00100 | ||
| 0.149 | 0.02 | 0.149 | Acetylcholine M3 receptor agonist | 0.141 0.024 DBMET00100 0.078 0.062 DBMET00101 | ||
| 0.141 | 0.011 | 0.162 | Protein kinase B alpha inhibitor | 0.162 0.007 DBMET00100 0.074 0.044 DBMET00101 | DBMET00100 | |
| 0.181 | 0.053 | 0.181 | Protein-tyrosine kinase Lyn inhibitor | 0.161 0.06 DBMET00100 0.118 0.087 DBMET00101 | ||
| 0.133 | 0.005 | 0.2 | 5 Hydroxytryptamine 2 agonist | 0.2 0.004 DBMET00100 | DBMET00100 | |
| 0.157 | 0.03 | 0.181 | Death-associated protein kinase 1 inhibitor | 0.181 0.013 DBMET00100 0.139 0.059 DBMET00101 0.121 0.109 DBMET03597 | DBMET00100 | |
| 0.135 | 0.008 | 0.153 | Toll-Like receptor 7 antagonist | 0.153 0.005 DBMET00100 | DBMET00100 | |
| 0.129 | 0.002 | 0.129 | Histamine H4 receptor agonist | 0.087 0.003 DBMET00100 0.022 0.01 DBMET00101 | ||
| 0.153 | 0.027 | 0.2 | Activin receptor-like kinase 4 inhibitor | 0.2 0.014 DBMET00100 0.101 0.083 DBMET00101 | DBMET00100 | |
| 0.182 | 0.056 | 0.182 | ATPase inhibitor | 0.163 0.081 DBMET00100 | ||
| 0.129 | 0.003 | 0.129 | Potassium channel small-conductance Ca-activated activator | 0.108 0.004 DBMET00100 0.053 0.01 DBMET00101 | ||
| 0.193 | 0.071 | 0.23 | CDC-like kinase 4 inhibitor | 0.23 0.054 DBMET00100 | DBMET00100 | |
| 0.177 | 0.054 | 0.179 | Cyclin-dependent kinase 8 inhibitor | 0.179 0.052 DBMET00100 | DBMET00100 | |
| 0.18 | 0.058 | 0.386 | Polo-like kinase-3 inhibitor | 0.141 0.094 DBMET00100 0.386 0.004 DBMET00101 | DBMET00101 | |
| 0.145 | 0.024 | 0.195 | Protein kinase C delta inhibitor | 0.169 0.014 DBMET00100 0.195 0.009 DBMET00101 0.133 0.029 DBMET00102 0.152 0.02 DBMET03597 | DBMET00101 | |
| 0.154 | 0.034 | 0.154 | Polo-like kinase-4 inhibitor | 0.114 0.062 DBMET00100 | ||
| 0.159 | 0.04 | 0.159 | Antibacterial (Helicobacter pylori) | 0.149 0.047 DBMET00100 | ||
| 0.138 | 0.019 | 0.155 | Protein kinase B gamma inhibitor | 0.155 0.015 DBMET00100 | DBMET00100 | |
| 0.127 | 0.01 | 0.127 | 5 Hydroxytryptamine 5A antagonist | 0.112 0.013 DBMET00100 | ||
| 0.161 | 0.046 | 0.18 | MAP3K9 inhibitor | 0.164 0.041 DBMET00100 0.173 0.032 DBMET00102 0.18 0.026 DBMET03597 | DBMET03597 | |
| 0.156 | 0.041 | 0.156 | Platelet activating factor antagonist | 0.12 0.063 DBMET00100 0.149 0.045 DBMET00101 | ||
| 0.167 | 0.053 | 0.167 | RET inhibitor | 0.129 0.073 DBMET00100 | ||
| 0.157 | 0.043 | 0.157 | Nav1.3 sodium channel blocker | 0.107 0.09 DBMET00100 | ||
| 0.124 | 0.011 | 0.124 | 5 Hydroxytryptamine 5 antagonist | 0.108 0.014 DBMET00100 | ||
| 0.135 | 0.024 | 0.257 | 5 Hydroxytryptamine agonist | 0.257 0.01 DBMET00100 | DBMET00100 | |
| 0.135 | 0.027 | 0.135 | Insulin growth factor antagonist | 0.113 0.038 DBMET00100 | ||
| 0.131 | 0.024 | 0.249 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.249 0.009 DBMET00100 0.073 0.056 DBMET00101 | DBMET00100 | |
| 0.193 | 0.086 | 0.211 | Platelet aggregation inhibitor | 0.192 0.087 DBMET00100 0.211 0.074 DBMET00101 0.171 0.106 DBMET00102 0.165 0.111 DBMET03597 | DBMET00101 | |
| 0.162 | 0.059 | 0.173 | Protein kinase (CK1) inhibitor | 0.173 0.052 DBMET00100 | DBMET00100 | |
| 0.129 | 0.026 | 0.129 | Insulin like growth factor 1 antagonist | 0.106 0.038 DBMET00100 | ||
| 0.161 | 0.059 | 0.161 | Tyrosine-protein kinase receptor antagonist | 0.147 0.065 DBMET00100 | ||
| 0.178 | 0.077 | 0.178 | Tyrosine kinase inhibitor | 0.138 0.096 DBMET00100 0.146 0.091 DBMET00101 | ||
| 0.165 | 0.067 | 0.165 | Cyclin-dependent kinase 3 inhibitor | 0.141 0.12 DBMET00100 | ||
| 0.129 | 0.031 | 0.144 | Phosphodiesterase 7B inhibitor | 0.144 0.024 DBMET00100 0.099 0.057 DBMET00101 | DBMET00100 | |
| 0.125 | 0.028 | 0.165 | Pim-3 kinase inhibitor | 0.165 0.014 DBMET00100 | DBMET00100 | |
| 0.199 | 0.101 | 0.241 | RNA-directed DNA polymerase inhibitor | 0.183 0.127 DBMET00100 0.241 0.055 DBMET00102 0.231 0.063 DBMET03597 | DBMET00102 | |
| 0.134 | 0.037 | 0.217 | Fibroblast growth factor 1 antagonist | 0.098 0.059 DBMET00100 0.217 0.013 DBMET00101 | DBMET00101 | |
| 0.137 | 0.04 | 0.192 | Antiadrenergic | 0.16 0.033 DBMET00100 0.192 0.026 DBMET00101 | DBMET00101 | |
| 0.103 | 0.006 | 0.103 | Corticotropin releasing factor 2 receptor antagonist | 0.096 0.008 DBMET00100 | ||
| 0.114 | 0.018 | 0.124 | Protein kinase B beta inhibitor | 0.124 0.014 DBMET00100 0.07 0.058 DBMET00101 | DBMET00100 | |
| 0.104 | 0.009 | 0.104 | Dopamine D5 antagonist | 0.053 0.023 DBMET00100 0.079 0.012 DBMET00101 | ||
| 0.181 | 0.085 | 0.181 | Growth factor agonist | 0.164 0.113 DBMET00100 | ||
| 0.121 | 0.026 | 0.142 | I kappa B kinase inhibitor | 0.142 0.018 DBMET00100 | DBMET00100 | |
| 0.137 | 0.043 | 0.141 | Interleukin 8 antagonist | 0.141 0.041 DBMET00100 | DBMET00100 | |
| 0.134 | 0.039 | 0.19 | Adrenaline antagonist | 0.157 0.033 DBMET00100 0.19 0.025 DBMET00101 | DBMET00101 | |
| 0.107 | 0.013 | 0.107 | Dopamine D4 agonist | 0.071 0.022 DBMET00100 | ||
| 0.116 | 0.022 | 0.116 | Phosphodiesterase 11A inhibitor | 0.102 0.03 DBMET00100 | ||
| 0.116 | 0.022 | 0.116 | Phosphodiesterase XI inhibitor | 0.102 0.03 DBMET00100 | ||
| 0.128 | 0.034 | 0.189 | Acetylcholine agonist | 0.106 0.043 DBMET00100 0.189 0.016 DBMET00101 | DBMET00101 | |
| 0.119 | 0.026 | 0.119 | Phosphodiesterase 6D inhibitor | 0.089 0.078 DBMET00100 0.109 0.037 DBMET00102 | ||
| 0.147 | 0.054 | 0.201 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.124 0.066 DBMET00100 0.201 0.037 DBMET00101 | DBMET00101 | |
| 0.133 | 0.04 | 0.133 | Transcription factor STAT6 inhibitor | 0.132 0.041 DBMET00100 0.103 0.099 DBMET00102 | ||
| 0.117 | 0.024 | 0.117 | Glutamate release inhibitor | 0.083 0.082 DBMET00100 | ||
| 0.179 | 0.088 | 0.216 | Death-associated protein kinase 3 inhibitor | 0.216 0.066 DBMET00100 | DBMET00100 | |
| 0.181 | 0.09 | 0.192 | Clk dual-specificity kinase inhibitor | 0.192 0.084 DBMET00100 | DBMET00100 | |
| 0.129 | 0.039 | 0.129 | Multidrug resistance-associated protein 1 inhibitor | 0.108 0.065 DBMET00100 0.127 0.041 DBMET00102 0.107 0.066 DBMET03597 | ||
| 0.145 | 0.056 | 0.145 | Protein kinase (CK1) delta inhibitor | 0.138 0.061 DBMET00100 | ||
| 0.097 | 0.01 | 0.097 | Potassium channel (Ca-activated) blocker | 0.09 0.013 DBMET00100 0.061 0.039 DBMET00101 | ||
| 0.148 | 0.061 | 0.168 | Cyclin-dependent kinase 7 inhibitor | 0.168 0.048 DBMET00100 | DBMET00100 | |
| 0.101 | 0.014 | 0.113 | Alpha 2 adrenoreceptor agonist | 0.113 0.011 DBMET00100 | DBMET00100 | |
| 0.115 | 0.028 | 0.166 | MAP-kinase-activated kinase inhibitor | 0.166 0.01 DBMET00100 | DBMET00100 | |
| 0.133 | 0.049 | 0.164 | Cyclin-dependent kinase 1 inhibitor | 0.164 0.036 DBMET00100 | DBMET00100 | |
| 0.12 | 0.036 | 0.172 | NMDA receptor antagonist | 0.172 0.019 DBMET00100 | DBMET00100 | |
| 0.102 | 0.019 | 0.109 | Acetylcholine M5 receptor agonist | 0.109 0.015 DBMET00100 | DBMET00100 | |
| 0.15 | 0.067 | 0.17 | Glycogen synthase kinase-3 alpha inhibitor | 0.17 0.053 DBMET00100 | DBMET00100 | |
| 0.098 | 0.015 | 0.131 | Pim-2 kinase inhibitor | 0.131 0.009 DBMET00100 | DBMET00100 | |
| 0.092 | 0.01 | 0.096 | MDM2 inhibitor | 0.096 0.008 DBMET00100 | DBMET00100 | |
| 0.097 | 0.015 | 0.102 | Protein kinase C beta inhibitor | 0.087 0.022 DBMET00100 0.101 0.013 DBMET00102 0.102 0.013 DBMET03597 | DBMET03597 | |
| 0.148 | 0.066 | 0.148 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.143 0.069 DBMET00100 | ||
| 0.143 | 0.063 | 0.191 | Heat shock protein 70 antagonist | 0.191 0.008 DBMET00102 0.154 0.038 DBMET03597 | DBMET00102 | |
| 0.144 | 0.065 | 0.179 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.133 0.072 DBMET00100 0.179 0.048 DBMET00101 | DBMET00101 | |
| 0.114 | 0.036 | 0.114 | mTOR complex 1 inhibitor | 0.11 0.042 DBMET00100 | ||
| 0.1 | 0.022 | 0.158 | Protein kinase C alpha inhibitor | 0.125 0.015 DBMET00100 0.137 0.012 DBMET00102 0.158 0.009 DBMET03597 | DBMET03597 | |
| 0.103 | 0.027 | 0.153 | MAP-kinase-activated kinase 2 inhibitor | 0.153 0.01 DBMET00100 | DBMET00100 | |
| 0.11 | 0.034 | 0.11 | Phosphodiesterase I inhibitor | |||
| 0.133 | 0.058 | 0.24 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.115 0.073 DBMET00100 0.24 0.019 DBMET00101 | DBMET00101 | |
| 0.133 | 0.058 | 0.24 | Abl kinase inhibitor | 0.115 0.073 DBMET00100 0.24 0.019 DBMET00101 | DBMET00101 | |
| 0.08 | 0.005 | 0.187 | 5 Hydroxytryptamine 2B agonist | 0.187 0.003 DBMET00100 0.043 0.02 DBMET00101 | DBMET00100 | |
| 0.078 | 0.004 | 0.078 | Histamine H1 receptor agonist | 0.075 0.004 DBMET00100 0.054 0.014 DBMET00101 | ||
| 0.129 | 0.056 | 0.196 | DNA repair enzyme inhibitor | 0.118 0.076 DBMET00100 0.196 0.009 DBMET00102 0.186 0.011 DBMET03597 | DBMET00102 | |
| 0.175 | 0.104 | 0.175 | Neurotrophic factor enhancer | 0.17 0.11 DBMET00100 | ||
| 0.075 | 0.007 | 0.075 | Acetylcholine M4 receptor agonist | 0.059 0.009 DBMET00100 | ||
| 0.127 | 0.06 | 0.127 | Aurora-B kinase inhibitor | 0.122 0.063 DBMET00100 | ||
| 0.24 | 0.173 | 0.24 | 15-Lipoxygenase inhibitor | |||
| 0.155 | 0.089 | 0.183 | Neurotensin receptor agonist | 0.183 0.047 DBMET00100 | DBMET00100 | |
| 0.088 | 0.022 | 0.088 | MAP kinase 7 inhibitor | |||
| 0.089 | 0.026 | 0.108 | MAP kinase kinase 7 inhibitor | 0.108 0.008 DBMET00100 | DBMET00100 | |
| 0.097 | 0.035 | 0.124 | Glycine receptor antagonist | 0.124 0.016 DBMET00100 0.077 0.061 DBMET03597 | DBMET00100 | |
| 0.08 | 0.018 | 0.089 | Toll-Like receptor 8 antagonist | 0.089 0.013 DBMET00100 | DBMET00100 | |
| 0.083 | 0.021 | 0.185 | Acetylcholine muscarinic agonist | 0.065 0.03 DBMET00100 0.185 0.007 DBMET00101 | DBMET00101 | |
| 0.118 | 0.057 | 0.118 | EphA2 antagonist | 0.098 0.077 DBMET00100 | ||
| 0.117 | 0.056 | 0.117 | Aurora-A kinase inhibitor | 0.102 0.065 DBMET00100 | ||
| 0.175 | 0.114 | 0.175 | Dyrk kinase inhibitor | 0.172 0.116 DBMET00100 | ||
| 0.067 | 0.007 | 0.067 | Protein kinase (CK1) epsilon inhibitor | 0.061 0.008 DBMET00100 | ||
| 0.097 | 0.037 | 0.097 | Janus tyrosine kinase 2 inhibitor | 0.089 0.042 DBMET00100 | ||
| 0.077 | 0.018 | 0.077 | Phosphodiesterase 1A inhibitor | 0.057 0.048 DBMET00100 | ||
| 0.109 | 0.05 | 0.16 | Pim-1 kinase inhibitor | 0.16 0.024 DBMET00100 0.081 0.08 DBMET03597 | DBMET00100 | |
| 0.102 | 0.044 | 0.116 | Histamine N-methyltransferase inhibitor | 0.116 0.033 DBMET00100 0.092 0.054 DBMET03597 | DBMET00100 | |
| 0.098 | 0.04 | 0.098 | GABA A receptor agonist | 0.098 0.04 DBMET00100 | ||
| 0.127 | 0.069 | 0.165 | Cyclin-dependent kinase inhibitor | 0.165 0.049 DBMET00100 | DBMET00100 | |
| 0.088 | 0.03 | 0.088 | Phosphodiesterase VI inhibitor | |||
| 0.133 | 0.076 | 0.133 | Aurora-C kinase inhibitor | 0.132 0.079 DBMET00100 | ||
| 0.067 | 0.009 | 0.067 | Kainate receptor 2 antagonist | 0.061 0.011 DBMET00100 | ||
| 0.072 | 0.015 | 0.117 | NMDA receptor subunit 3B antagonist | 0.117 0.009 DBMET00100 | DBMET00100 | |
| 0.072 | 0.016 | 0.072 | 5 Hydroxytryptamine 4 antagonist | 0.053 0.033 DBMET00100 | ||
| 0.143 | 0.088 | 0.172 | Src kinase inhibitor | 0.116 0.112 DBMET00100 0.172 0.069 DBMET00101 | DBMET00101 | |
| 0.113 | 0.058 | 0.169 | Granulocyte macrophage colony stimulating factor antagonist | 0.089 0.086 DBMET00100 0.169 0.03 DBMET00101 | DBMET00101 | |
| 0.079 | 0.024 | 0.158 | Protein kinase C eta inhibitor | 0.056 0.037 DBMET00100 0.158 0.007 DBMET00102 0.151 0.007 DBMET03597 | DBMET00102 | |
| 0.063 | 0.008 | 0.063 | Acid-sensing ion channel blocker | 0.057 0.011 DBMET00100 0.037 0.033 DBMET00101 | ||
| 0.088 | 0.034 | 0.153 | Check point kinase 1 inhibitor | 0.153 0.014 DBMET00100 | DBMET00100 | |
| 0.153 | 0.099 | 0.171 | Catenin beta inhibitor | 0.171 0.065 DBMET00100 | DBMET00100 | |
| 0.088 | 0.034 | 0.116 | Phosphodiesterase V inhibitor | 0.071 0.051 DBMET00100 0.116 0.021 DBMET00101 | DBMET00101 | |
| 0.072 | 0.018 | 0.072 | 5 Hydroxytryptamine 7 agonist | 0.062 0.029 DBMET00100 | ||
| 0.076 | 0.022 | 0.076 | Cyclin D1 inhibitor | 0.071 0.027 DBMET00100 | ||
| 0.062 | 0.009 | 0.065 | Vascular adhesion protein 1 inhibitor | 0.065 0.008 DBMET00100 | DBMET00100 | |
| 0.073 | 0.019 | 0.073 | AMPA receptor antagonist | 0.067 0.022 DBMET00100 | ||
| 0.077 | 0.024 | 0.077 | Cyclin-dependent kinase 6 inhibitor | 0.077 0.025 DBMET00100 | ||
| 0.09 | 0.038 | 0.092 | Transforming growth factor beta 3 antagonist | 0.089 0.04 DBMET00100 0.092 0.035 DBMET00101 | DBMET00101 | |
| 0.063 | 0.011 | 0.063 | Benzodiazepine antagonist | 0.062 0.012 DBMET00100 | ||
| 0.062 | 0.011 | 0.076 | GABA B receptor antagonist | 0.076 0.007 DBMET00100 | DBMET00100 | |
| 0.076 | 0.025 | 0.092 | I kappa B kinase 2 inhibitor | 0.092 0.016 DBMET00100 | DBMET00100 | |
| 0.123 | 0.072 | 0.123 | c-Src kinase inhibitor | |||
| 0.076 | 0.025 | 0.076 | Phosphodiesterase 1B inhibitor | |||
| 0.069 | 0.019 | 0.161 | Acetylcholine M1 receptor agonist | 0.049 0.026 DBMET00100 0.161 0.006 DBMET00101 | DBMET00101 | |
| 0.085 | 0.036 | 0.114 | Phosphodiesterase 5A inhibitor | 0.066 0.055 DBMET00100 0.114 0.021 DBMET00101 | DBMET00101 | |
| 0.082 | 0.034 | 0.115 | Cyclin-dependent kinase 4 inhibitor | 0.115 0.02 DBMET00100 | DBMET00100 | |
| 0.138 | 0.089 | 0.141 | MAP kinase 3 inhibitor | 0.141 0.083 DBMET00100 | DBMET00100 | |
| 0.096 | 0.048 | 0.096 | Stem cell growth factor agonist | |||
| 0.114 | 0.066 | 0.149 | Sphingosine 1-phosphate receptor 2 agonist | 0.149 0.027 DBMET00100 | DBMET00100 | |
| 0.092 | 0.045 | 0.095 | mTOR complex 2 inhibitor | 0.095 0.039 DBMET00100 | DBMET00100 | |
| 0.081 | 0.035 | 0.117 | I kappa B kinase 1 inhibitor | 0.117 0.016 DBMET00100 | DBMET00100 | |
| 0.064 | 0.018 | 0.185 | 5 Hydroxytryptamine 2C agonist | 0.185 0.004 DBMET00100 0.041 0.036 DBMET03597 | DBMET00100 | |
| 0.08 | 0.035 | 0.125 | Phospholipase D inhibitor | 0.125 0.005 DBMET00100 | DBMET00100 | |
| 0.103 | 0.059 | 0.111 | Cyclin-dependent kinase 9 inhibitor | 0.111 0.052 DBMET00100 | DBMET00100 | |
| 0.079 | 0.036 | 0.105 | CDC7 inhibitor | 0.105 0.021 DBMET00100 | DBMET00100 | |
| 0.137 | 0.094 | 0.398 | Hexokinase inhibitor | 0.167 0.06 DBMET00100 0.375 0.005 DBMET00102 0.398 0.004 DBMET03597 | DBMET03597 | |
| 0.128 | 0.085 | 0.128 | Growth factor antagonist | 0.108 0.105 DBMET00101 | ||
| 0.07 | 0.028 | 0.07 | 5 Hydroxytryptamine 1 agonist | |||
| 0.091 | 0.049 | 0.091 | Leucine-rich repeat kinase 2 inhibitor | 0.072 0.066 DBMET00100 | ||
| 0.072 | 0.03 | 0.086 | Cyclin B1 inhibitor | 0.086 0.017 DBMET00100 | DBMET00100 | |
| 0.079 | 0.038 | 0.079 | Dopamine agonist | |||
| 0.127 | 0.086 | 0.257 | Protein kinase C nu inhibitor | 0.156 0.067 DBMET00100 0.21 0.044 DBMET00102 0.257 0.033 DBMET03597 | DBMET03597 | |
| 0.161 | 0.121 | 0.161 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.159 0.123 DBMET00100 | ||
| 0.116 | 0.075 | 0.138 | MAP kinase 12 inhibitor | 0.138 0.051 DBMET00100 | DBMET00100 | |
| 0.155 | 0.115 | 0.209 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.209 0.07 DBMET00100 | DBMET00100 | |
| 0.054 | 0.014 | 0.054 | Nerve growth factor antagonist | 0.045 0.026 DBMET00100 | ||
| 0.128 | 0.089 | 0.131 | Protein kinase (CK1) gamma 1 inhibitor | 0.131 0.086 DBMET00100 | DBMET00100 | |
| 0.132 | 0.093 | 0.136 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.136 0.088 DBMET00100 | DBMET00100 | |
| 0.091 | 0.052 | 0.148 | Protein kinase A inhibitor | 0.122 0.033 DBMET00100 0.116 0.036 DBMET00102 0.148 0.025 DBMET03597 | DBMET03597 | |
| 0.112 | 0.074 | 0.112 | TRKA antagonist | 0.107 0.081 DBMET00100 | ||
| 0.084 | 0.046 | 0.09 | Nicotinic alpha4beta2 receptor antagonist | 0.09 0.04 DBMET00100 0.08 0.05 DBMET00101 | DBMET00100 | |
| 0.112 | 0.075 | 0.153 | Acetylcholine muscarinic antagonist | 0.153 0.042 DBMET00101 | DBMET00101 | |
| 0.093 | 0.056 | 0.133 | Polo-like kinase-1 inhibitor | 0.133 0.024 DBMET00101 | DBMET00101 | |
| 0.101 | 0.066 | 0.114 | Urease inhibitor | 0.114 0.051 DBMET00100 | DBMET00100 | |
| 0.175 | 0.139 | 0.179 | DNA damaging | 0.179 0.135 DBMET00100 0.177 0.138 DBMET00102 0.178 0.136 DBMET03597 | DBMET00100 | |
| 0.075 | 0.039 | 0.075 | Tyk2 inhibitor | 0.075 0.039 DBMET00100 | ||
| 0.083 | 0.047 | 0.083 | Fibroblast growth factor 3 antagonist | |||
| 0.063 | 0.029 | 0.076 | Cyclin B2 inhibitor | 0.076 0.017 DBMET00100 | DBMET00100 | |
| 0.087 | 0.053 | 0.087 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.079 0.065 DBMET00100 | ||
| 0.083 | 0.05 | 0.083 | ErbB-4 antagonist | |||
| 0.042 | 0.009 | 0.042 | Adenosine uptake inhibitor | |||
| 0.137 | 0.104 | 0.137 | Protein kinase (CK1) gamma 3 inhibitor | 0.135 0.108 DBMET00100 | ||
| 0.06 | 0.027 | 0.06 | 5 Hydroxytryptamine 1B agonist | |||
| 0.061 | 0.03 | 0.076 | Cyclin B inhibitor | 0.076 0.018 DBMET00100 | DBMET00100 | |
| 0.057 | 0.026 | 0.057 | Potassium channel (Inward rectifier) blocker | 0.05 0.034 DBMET00100 | ||
| 0.077 | 0.047 | 0.077 | Polo-like kinase-2 inhibitor | |||
| 0.103 | 0.073 | 0.103 | CDC-like kinase 3 inhibitor | |||
| 0.05 | 0.021 | 0.05 | Phosphodiesterase 6C inhibitor | |||
| 0.075 | 0.048 | 0.075 | Telomerase inhibitor | 0.064 0.059 DBMET00100 0.072 0.05 DBMET00101 | ||
| 0.063 | 0.035 | 0.063 | Dopamine uptake inhibitor | |||
| 0.133 | 0.105 | 0.153 | MAP kinase kinase 4 inhibitor | 0.153 0.056 DBMET00100 0.132 0.107 DBMET00102 0.15 0.061 DBMET03597 | DBMET00100 | |
| 0.099 | 0.072 | 0.214 | AMP-activated protein kinase stimulant | 0.111 0.057 DBMET00100 0.178 0.015 DBMET00102 0.214 0.009 DBMET03597 | DBMET03597 | |
| 0.036 | 0.009 | 0.036 | 5 Hydroxytryptamine 1F agonist | |||
| 0.054 | 0.027 | 0.054 | Bromodomain-containing protein 3 inhibitor | 0.045 0.041 DBMET00100 | ||
| 0.114 | 0.088 | 0.202 | Phosphodiesterase inhibitor | 0.118 0.084 DBMET00100 0.202 0.034 DBMET00101 | DBMET00101 | |
| 0.104 | 0.078 | 0.104 | Interleukin 2 antagonist | |||
| 0.036 | 0.01 | 0.037 | 5 Hydroxytryptamine 6 agonist | 0.037 0.009 DBMET00100 | DBMET00100 | |
| 0.049 | 0.024 | 0.121 | Poly(ADP-ribose) polymerase inhibitor | 0.065 0.015 DBMET00100 0.121 0.006 DBMET00101 | DBMET00101 | |
| 0.064 | 0.039 | 0.085 | NMDA 2C receptor antagonist | 0.085 0.022 DBMET00100 | DBMET00100 | |
| 0.06 | 0.037 | 0.065 | Protein kinase C theta inhibitor | 0.063 0.032 DBMET00100 0.065 0.029 DBMET00101 | DBMET00101 | |
| 0.074 | 0.051 | 0.143 | Adenosine A3 receptor antagonist | 0.143 0.013 DBMET00102 0.134 0.015 DBMET03597 | DBMET00102 | |
| 0.055 | 0.033 | 0.055 | mTOR inhibitor | 0.047 0.042 DBMET00100 | ||
| 0.108 | 0.086 | 0.108 | MAP kinase kinase inhibitor | |||
| 0.133 | 0.111 | 0.144 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.144 0.1 DBMET00100 | DBMET00100 | |
| 0.178 | 0.156 | 0.454 | DNA synthesis inhibitor | 0.193 0.134 DBMET00100 0.431 0.018 DBMET00102 0.454 0.017 DBMET03597 | DBMET03597 | |
| 0.053 | 0.031 | 0.053 | Adenosine A2b receptor antagonist | 0.044 0.042 DBMET00100 | ||
| 0.064 | 0.043 | 0.068 | 5 Hydroxytryptamine uptake inhibitor | 0.068 0.04 DBMET00100 | DBMET00100 | |
| 0.13 | 0.109 | 0.144 | CDC-like kinase 2 inhibitor | 0.144 0.097 DBMET00100 | DBMET00100 | |
| 0.044 | 0.023 | 0.072 | NMDA receptor subunit 3A antagonist | 0.072 0.014 DBMET00100 | DBMET00100 | |
| 0.055 | 0.034 | 0.065 | Nicotinic alpha3beta2 receptor antagonist | 0.051 0.041 DBMET00100 0.065 0.021 DBMET00101 | DBMET00101 | |
| 0.056 | 0.036 | 0.104 | Glucosylceramidase inhibitor | 0.101 0.008 DBMET00100 0.055 0.038 DBMET00102 0.104 0.007 DBMET03597 | DBMET03597 | |
| 0.062 | 0.042 | 0.066 | Adrenaline uptake inhibitor | 0.066 0.038 DBMET00100 0.063 0.041 DBMET00101 | DBMET00100 | |
| 0.032 | 0.012 | 0.034 | Kainate receptor 4 antagonist | 0.034 0.011 DBMET00100 | DBMET00100 | |
| 0.1 | 0.081 | 0.124 | MAP kinase 13 inhibitor | 0.124 0.052 DBMET00100 | DBMET00100 | |
| 0.064 | 0.046 | 0.075 | Aryl hydrocarbon receptor antagonist | 0.075 0.032 DBMET00100 | DBMET00100 | |
| 0.034 | 0.016 | 0.034 | Phosphodiesterase 6B inhibitor | |||
| 0.098 | 0.081 | 0.098 | Glycogen synthase kinase-3 inhibitor | |||
| 0.098 | 0.081 | 0.098 | Glycogen synthase kinase-3 beta inhibitor | 0.093 0.087 DBMET00100 | ||
| 0.131 | 0.115 | 0.131 | Ca2+-transporting ATPase inhibitor | |||
| 0.07 | 0.055 | 0.07 | MAP3K7 inhibitor | |||
| 0.031 | 0.017 | 0.042 | Poly(ADP-ribose) polymerase 2 inhibitor | 0.042 0.011 DBMET00100 | DBMET00100 | |
| 0.039 | 0.025 | 0.114 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.053 0.016 DBMET00100 0.114 0.005 DBMET00101 | DBMET00101 | |
| 0.047 | 0.033 | 0.049 | CC chemokine 4 receptor antagonist | 0.049 0.028 DBMET00100 | DBMET00100 | |
| 0.112 | 0.099 | 0.121 | Protein kinase (CK1) gamma inhibitor | 0.121 0.089 DBMET00100 | DBMET00100 | |
| 0.056 | 0.043 | 0.232 | Adenosine A1 receptor antagonist | 0.232 0.009 DBMET00102 0.19 0.012 DBMET03597 | DBMET00102 | |
| 0.042 | 0.029 | 0.042 | Smo receptor antagonist | |||
| 0.04 | 0.027 | 0.046 | Cyclin D3 inhibitor | 0.046 0.023 DBMET00100 | DBMET00100 | |
| 0.039 | 0.028 | 0.039 | AMPA 4 receptor antagonist | 0.039 0.028 DBMET00100 | ||
| 0.048 | 0.036 | 0.063 | Transforming growth factor beta 1 antagonist | 0.063 0.024 DBMET00100 | DBMET00100 | |
| 0.058 | 0.048 | 0.058 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.042 | 0.032 | 0.068 | Alpha 1L adrenoreceptor agonist | 0.068 0.005 DBMET00100 | DBMET00100 | |
| 0.103 | 0.093 | 0.103 | Epidermal growth factor receptor kinase inhibitor | |||
| 0.092 | 0.083 | 0.15 | Beta glucuronidase inhibitor | 0.15 0.025 DBMET00100 0.138 0.031 DBMET03597 | DBMET00100 | |
| 0.057 | 0.048 | 0.068 | Cannabinoid CB1 receptor antagonist | 0.068 0.036 DBMET00100 | DBMET00100 | |
| 0.056 | 0.047 | 0.062 | Cyclin A1 inhibitor | 0.062 0.034 DBMET00100 | DBMET00100 | |
| 0.034 | 0.025 | 0.035 | Benzodiazepine receptor peripheral-type antagonist | 0.035 0.021 DBMET00100 | DBMET00100 | |
| 0.042 | 0.034 | 0.046 | Phosphodiesterase X inhibitor | 0.046 0.03 DBMET00100 | DBMET00100 | |
| 0.042 | 0.034 | 0.046 | Phosphodiesterase 10A inhibitor | 0.046 0.03 DBMET00100 | DBMET00100 | |
| 0.037 | 0.028 | 0.039 | DNA gyrase subunit B inhibitor | 0.039 0.024 DBMET00100 | DBMET00100 | |
| 0.092 | 0.083 | 0.204 | DNA intercalator | 0.128 0.053 DBMET00101 0.204 0.024 DBMET00102 0.2 0.026 DBMET03597 | DBMET00102 | |
| 0.116 | 0.108 | 0.116 | Sphingosine 1-phosphate receptor 2 antagonist | 0.115 0.11 DBMET00100 | ||
| 0.03 | 0.023 | 0.03 | LIM domain kinase 2 inhibitor | 0.029 0.025 DBMET00100 | ||
| 0.038 | 0.031 | 0.043 | Kainate receptor antagonist | 0.043 0.026 DBMET00100 | DBMET00100 | |
| 0.136 | 0.129 | 0.136 | Pyruvate kinase inhibitor | |||
| 0.083 | 0.077 | 0.083 | Platelet activating factor alpha antagonist | |||
| 0.058 | 0.052 | 0.062 | DNA gyrase inhibitor | 0.062 0.046 DBMET00100 | DBMET00100 | |
| 0.128 | 0.123 | 0.128 | TRKC antagonist | |||
| 0.01 | 0.006 | 0.01 | CXC chemokine 3 receptor agonist | 0.009 0.008 DBMET00100 | ||
| 0.031 | 0.028 | 0.035 | ATR kinase inhibitor | 0.035 0.019 DBMET00100 | DBMET00100 | |
| 0.022 | 0.02 | 0.022 | Phosphodiesterase 6G inhibitor | |||
| 0.022 | 0.02 | 0.022 | Phosphodiesterase 6H inhibitor | |||
| 0.053 | 0.051 | 0.07 | Acetylcholine M2 receptor antagonist | 0.07 0.037 DBMET00101 | DBMET00101 | |
| 0.019 | 0.017 | 0.02 | Kainate receptor 5 antagonist | 0.02 0.015 DBMET00100 | DBMET00100 | |
| 0.019 | 0.017 | 0.033 | Imidazoline I1 receptor antagonist | 0.033 0.006 DBMET00100 | DBMET00100 | |
| 0.098 | 0.096 | 0.138 | Acetylcholine antagonist | 0.138 0.057 DBMET00101 | DBMET00101 | |
| 0.069 | 0.067 | 0.069 | Vanilloid 4 agonist | |||
| 0.04 | 0.038 | 0.041 | 5 Hydroxytryptamine 1A agonist | 0.041 0.036 DBMET00100 | DBMET00100 | |
| 0.101 | 0.1 | 0.101 | TRKB antagonist | |||
| 0.099 | 0.097 | 0.148 | Cholinergic antagonist | 0.148 0.053 DBMET00101 | DBMET00101 | |
| 0.052 | 0.051 | 0.052 | Calcium channel T-type blocker | |||
| 0.086 | 0.085 | 0.114 | GABA C receptor rho-1 antagonist | 0.114 0.046 DBMET00100 | DBMET00100 | |
| 0.082 | 0.081 | 0.096 | Protein kinase (CK2) inhibitor | 0.096 0.067 DBMET00100 | DBMET00100 | |
| 0.033 | 0.032 | 0.041 | Somatostatin 4 agonist | 0.041 0.021 DBMET00100 | DBMET00100 | |
| 0.046 | 0.045 | 0.046 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.05 | 0.049 | 0.08 | EphB4 antagonist | 0.08 0.023 DBMET00101 | DBMET00101 | |
| 0.024 | 0.024 | 0.034 | AMPA 1 receptor antagonist | 0.034 0.018 DBMET00100 | DBMET00100 | |
| 0.031 | 0.034 | 0.033 | Protein kinase C beta I inhibitor | 0.033 0.023 DBMET00102 0.032 0.029 DBMET03597 | DBMET00102 | |
| 0.074 | 0.076 | 0.089 | CDK/cyclin complex inhibitor | 0.089 0.06 DBMET00100 | DBMET00100 | |
| 0.016 | 0.019 | 0.02 | Kainate receptor 1 antagonist | 0.02 0.016 DBMET00100 | DBMET00100 | |
| 0.047 | 0.052 | 0.062 | CDK4/cyclin D1 inhibitor | 0.062 0.037 DBMET00100 | DBMET00100 | |
| 0.05 | 0.054 | 0.083 | Protein kinase C iota inhibitor | 0.083 0.024 DBMET00100 0.056 0.045 DBMET00102 0.08 0.026 DBMET03597 | DBMET00100 | |
| 0.029 | 0.034 | 0.103 | Phosphoglycerate kinase inhibitor | 0.103 0.007 DBMET00102 0.09 0.008 DBMET03597 | DBMET00102 | |
| 0.091 | 0.096 | 0.104 | Protein kinase (CK1) gamma 2 inhibitor | 0.104 0.08 DBMET00100 | DBMET00100 | |
| 0.071 | 0.078 | 0.088 | Neuropeptide Y antagonist | 0.088 0.049 DBMET00100 | DBMET00100 | |
| 0.049 | 0.057 | 0.064 | Adenosine A2a receptor antagonist | 0.064 0.041 DBMET00102 | DBMET00102 | |
| 0.077 | 0.087 | 0.166 | Vascular endothelial growth factor 1 antagonist | 0.166 0.035 DBMET00101 | DBMET00101 | |
| 0.017 | 0.028 | 0.024 | NMDA receptor glycine site antagonist | 0.024 0.018 DBMET00100 | DBMET00100 | |
| 0.047 | 0.059 | 0.057 | CDK4/cyclin D inhibitor | 0.057 0.043 DBMET00100 | DBMET00100 | |
| 0.025 | 0.039 | 0.046 | Methionyl aminopeptidase 1 inhibitor | 0.046 0.008 DBMET00100 | DBMET00100 | |
| 0.017 | 0.031 | 0.024 | Bombesin agonist | 0.024 0.013 DBMET00100 | DBMET00100 | |
| 0.074 | 0.088 | 0.105 | HIV-1 integrase (Overall Integration) inhibitor | 0.105 0.05 DBMET00100 | DBMET00100 | |
| 0.234 | 0.251 | 0.288 | 5 Hydroxytryptamine release inhibitor | 0.288 0.179 DBMET00100 | DBMET00100 | |
| 0.054 | 0.072 | 0.063 | Cannabinoid receptor antagonist | 0.063 0.058 DBMET00100 | DBMET00100 | |
| 0.013 | 0.032 | 0.019 | Bombesin 3 receptor agonist | 0.019 0.013 DBMET00100 | DBMET00100 | |
| 0.018 | 0.036 | 0.029 | AMPA 3 receptor antagonist | 0.029 0.021 DBMET00100 | DBMET00100 | |
| 0.053 | 0.071 | 0.099 | NMDA 2 receptor antagonist | 0.099 0.032 DBMET00100 | DBMET00100 | |
| 0.011 | 0.03 | 0.015 | Nicotinic alpha4 receptor agonist | 0.015 0.014 DBMET00100 | DBMET00100 | |
| 0.026 | 0.046 | 0.031 | CDK6/cyclin D3 inhibitor | 0.031 0.03 DBMET00100 | DBMET00100 | |
| 0.1 | 0.121 | 0.145 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.145 0.081 DBMET00100 | DBMET00100 | |
| 0.127 | 0.148 | 0.163 | 3C-like protease (Human coronavirus) inhibitor | 0.163 0.082 DBMET00100 | DBMET00100 | |
| 0.031 | 0.053 | 0.046 | Chemokine receptor agonist | 0.046 0.038 DBMET00100 | DBMET00100 | |
| 0.012 | 0.036 | 0.06 | Adenosine kinase inhibitor | 0.019 0.017 DBMET00100 0.038 0.007 DBMET00102 0.06 0.005 DBMET03597 | DBMET03597 | |
| 0.081 | 0.106 | 0.189 | Adenylate cyclase inhibitor | 0.189 0.028 DBMET00102 0.165 0.036 DBMET03597 | DBMET00102 | |
| 0.043 | 0.069 | 0.056 | NMDA receptor glycine site agonist | 0.056 0.05 DBMET00100 | DBMET00100 | |
| 0.055 | 0.081 | 0.065 | Transforming growth factor antagonist | 0.065 0.056 DBMET00100 | DBMET00100 | |
| 0.099 | 0.128 | 0.111 | Interleukin 1 antagonist | 0.111 0.103 DBMET00100 | DBMET00100 | |
| 0.071 | 0.102 | 0.233 | Ephrin antagonist | 0.233 0.017 DBMET00101 | DBMET00101 | |
| 0.14 | 0.174 | 0.232 | Spasmolytic | 0.232 0.099 DBMET00102 | DBMET00102 | |
| 0.008 | 0.049 | 0.019 | Alpha 2a adrenoreceptor agonist | 0.019 0.011 DBMET00100 | DBMET00100 | |
| 0.066 | 0.108 | 0.444 | Topoisomerase I inhibitor | 0.444 0.005 DBMET00102 0.444 0.005 DBMET03597 | DBMET03597 | |
| 0.04 | 0.083 | 0.082 | Phosphodiesterase III inhibitor | 0.082 0.034 DBMET00101 | DBMET00101 | |
| 0.066 | 0.114 | 0.255 | NADH dehydrogenase inhibitor | 0.086 0.063 DBMET00100 0.189 0.011 DBMET00102 0.255 0.008 DBMET03597 | DBMET03597 | |
| 0.047 | 0.102 | 0.068 | Rho-associated kinase I inhibitor | 0.068 0.059 DBMET00100 | DBMET00100 | |
| 0.047 | 0.104 | 0.065 | Nav1.8 sodium channel blocker | 0.065 0.063 DBMET00100 | DBMET00100 | |
| 0.072 | 0.138 | 0.108 | GABA C receptor antagonist | 0.108 0.066 DBMET00100 | DBMET00100 | |
| 0.013 | 0.079 | 0.029 | HCV NS5B polymerase inhibitor | 0.029 0.025 DBMET00102 | DBMET00102 | |
| 0.026 | 0.095 | 0.045 | Phenylethanolamine N methyltransferase inhibitor | 0.045 0.021 DBMET00100 | DBMET00100 | |
| 0.157 | 0.23 | 0.43 | Vasodilator, coronary | 0.43 0.027 DBMET00102 0.418 0.03 DBMET03597 | DBMET00102 | |
| 0.014 | 0.09 | 0.057 | Kinesin-like protein 1 inhibitor | 0.057 0.014 DBMET00101 | DBMET00101 | |
| 0.014 | 0.09 | 0.057 | Kinesin antagonist | 0.057 0.014 DBMET00101 | DBMET00101 | |
| 0.098 | 0.177 | 0.124 | Hemostatic | 0.118 0.117 DBMET00102 0.124 0.107 DBMET03597 | DBMET03597 | |
| 0.167 | 0.246 | 0.242 | MAP kinase kinase 3 inhibitor | 0.239 0.044 DBMET00102 0.242 0.04 DBMET03597 | DBMET03597 | |
| 0.07 | 0.15 | 0.089 | Alpha 2d adrenoreceptor antagonist | 0.089 0.072 DBMET00100 | DBMET00100 | |
| 0.028 | 0.113 | 0.058 | Purinergic P2X4 antagonist | 0.057 0.017 DBMET00100 0.058 0.016 DBMET03597 | DBMET03597 | |
| 0.103 | 0.188 | 0.136 | Tumour necrosis factor antagonist | 0.136 0.119 DBMET00100 | DBMET00100 | |
| 0.08 | 0.168 | 0.275 | Cytidine deaminase inhibitor | 0.275 0.023 DBMET00102 0.186 0.054 DBMET03597 | DBMET00102 | |
| 0.015 | 0.107 | 0.112 | Purinergic P2Y antagonist | 0.112 0.008 DBMET00102 0.112 0.008 DBMET03597 | DBMET03597 | |
| 0.06 | 0.152 | 0.088 | DNA directed RNA polymerase inhibitor | 0.088 0.072 DBMET03597 | DBMET03597 | |
| 0.081 | 0.179 | 0.216 | Cholinergic | 0.216 0.04 DBMET00101 | DBMET00101 | |
| 0.128 | 0.228 | 0.206 | Superoxide dismutase inhibitor | 0.206 0.111 DBMET00100 | DBMET00100 | |
| 0.008 | 0.11 | 0.025 | Purinergic P2Y12 antagonist | 0.025 0.014 DBMET00102 0.022 0.017 DBMET03597 | DBMET00102 | |
| 0.028 | 0.131 | 0.049 | Myc inhibitor | 0.049 0.047 DBMET00100 | DBMET00100 | |
| 0.089 | 0.195 | 0.227 | Insulin secretagoues | 0.126 0.102 DBMET00100 0.2 0.036 DBMET00102 0.227 0.025 DBMET03597 | DBMET03597 | |
| 0.029 | 0.137 | 0.08 | Macrophage colony-stimulating factor 1 receptor antagonist | 0.08 0.041 DBMET00101 | DBMET00101 | |
| 0.05 | 0.17 | 0.13 | Topoisomerase II inhibitor | 0.123 0.065 DBMET00102 0.13 0.06 DBMET03597 | DBMET03597 | |
| 0.078 | 0.203 | 0.13 | Diuretic | 0.13 0.094 DBMET00102 | DBMET00102 | |
| 0.032 | 0.157 | 0.048 | Alpha 1b adrenoreceptor agonist | 0.048 0.04 DBMET00100 | DBMET00100 | |
| 0.163 | 0.289 | 0.323 | Analgesic | 0.323 0.124 DBMET00101 | DBMET00101 | |
| 0.014 | 0.143 | 0.059 | Phosphorylase inhibitor | 0.041 0.036 DBMET00102 0.059 0.025 DBMET03597 | DBMET03597 | |
| 0.146 | 0.281 | 0.288 | Antiobesity | 0.288 0.124 DBMET00100 | DBMET00100 | |
| 0.132 | 0.274 | 0.383 | Vasodilator, peripheral | 0.359 0.07 DBMET00102 0.383 0.061 DBMET03597 | DBMET03597 | |
| 0.086 | 0.228 | 0.374 | DNA methylase inhibitor | 0.374 0.013 DBMET00102 0.346 0.017 DBMET03597 | DBMET00102 | |
| 0.026 | 0.175 | 0.051 | Heparanase inhibitor | 0.051 0.042 DBMET03597 | DBMET03597 | |
| 0.13 | 0.279 | 0.418 | Immunomodulator | 0.418 0.039 DBMET00102 0.395 0.045 DBMET03597 | DBMET00102 | |
| 0.078 | 0.236 | 0.33 | DNA methyltransferase I inhibitor | 0.33 0.018 DBMET00102 0.307 0.024 DBMET03597 | DBMET00102 | |
| 0.011 | 0.176 | 0.053 | Guanylate cyclase inhibitor | 0.053 0.018 DBMET00102 0.05 0.021 DBMET03597 | DBMET00102 | |
| 0.081 | 0.246 | 0.236 | Interleukin agonist | 0.22 0.103 DBMET00102 0.236 0.09 DBMET03597 | DBMET03597 | |
| 0.056 | 0.225 | 0.092 | Hematopoietic | 0.091 0.048 DBMET00102 0.092 0.046 DBMET03597 | DBMET03597 | |
| 0.1 | 0.275 | 0.125 | CC chemokine 6 receptor antagonist | 0.125 0.094 DBMET00102 | DBMET00102 | |
| 0.108 | 0.294 | 0.251 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.251 0.042 DBMET00102 0.196 0.075 DBMET03597 | DBMET00102 | |
| 0.02 | 0.21 | 0.057 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.057 0.039 DBMET03597 | DBMET03597 | |
| 0.132 | 0.332 | 0.214 | Caspase 3 stimulant | 0.213 0.151 DBMET00102 0.214 0.149 DBMET03597 | DBMET03597 | |
| 0.037 | 0.261 | 0.175 | Aminoacyl-tRNA synthetase inhibitor | 0.151 0.019 DBMET00102 0.175 0.014 DBMET03597 | DBMET03597 | |
| 0.099 | 0.336 | 0.25 | Cholesterol antagonist | 0.25 0.125 DBMET00102 0.183 0.181 DBMET03597 | DBMET00102 | |
| 0.071 | 0.309 | 0.178 | Non-steroidal antiinflammatory agent | 0.178 0.089 DBMET00102 0.15 0.115 DBMET03597 | DBMET00102 | |
| 0.039 | 0.281 | 0.134 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.091 0.064 DBMET00102 0.134 0.032 DBMET03597 | DBMET03597 | |
| 0.046 | 0.289 | 0.114 | Neurotrophic factor | 0.114 0.106 DBMET00102 | DBMET00102 | |
| 0.023 | 0.314 | 0.067 | Purinergic P2X1 antagonist | 0.057 0.049 DBMET00102 0.067 0.034 DBMET03597 | DBMET03597 | |
| 0.104 | 0.401 | 0.155 | MAP kinase kinase 5 inhibitor | 0.155 0.133 DBMET03597 | DBMET03597 | |
| 0.012 | 0.319 | 0.055 | Biliverdin reductase inhibitor | 0.055 0.046 DBMET03597 | DBMET03597 | |
| 0.103 | 0.415 | 0.236 | Apoptosis antagonist | 0.236 0.141 DBMET00102 0.227 0.15 DBMET03597 | DBMET00102 | |
| 0.114 | 0.436 | 0.352 | Apoptosis agonist | 0.352 0.137 DBMET00102 0.327 0.154 DBMET03597 | DBMET00102 | |
| 0.065 | 0.391 | 0.16 | Phospholipase C inhibitor | 0.16 0.088 DBMET03597 | DBMET03597 | |
| 0.045 | 0.38 | 0.104 | Adenylate kinase inhibitor | 0.104 0.062 DBMET03597 | DBMET03597 | |
| 0.067 | 0.404 | 0.332 | Transcription factor NF kappa B inhibitor | 0.332 0.082 DBMET00102 0.325 0.084 DBMET03597 | DBMET00102 | |
| 0.005 | 0.366 | 0.025 | Sodium/glucose cotransporter inhibitor | 0.025 0.02 DBMET03597 | DBMET03597 | |
| 0.025 | 0.387 | 0.136 | UDP-glucose 4-epimerase inhibitor | 0.099 0.062 DBMET00102 0.136 0.034 DBMET03597 | DBMET03597 | |
| 0.079 | 0.452 | 0.439 | Antibacterial | 0.404 0.075 DBMET00102 0.439 0.061 DBMET03597 | DBMET03597 | |
| 0.037 | 0.415 | 0.327 | Immunostimulant | 0.294 0.08 DBMET00102 0.327 0.071 DBMET03597 | DBMET03597 | |
| 0.005 | 0.391 | 0.019 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.019 0.007 DBMET00102 0.019 0.007 DBMET03597 | DBMET03597 | |
| 0.043 | 0.443 | 0.284 | Vasodilator | 0.276 0.057 DBMET00102 0.284 0.054 DBMET03597 | DBMET03597 | |
| 0.04 | 0.448 | 0.296 | Platelet adhesion inhibitor | 0.256 0.048 DBMET00102 0.296 0.035 DBMET03597 | DBMET03597 | |
| 0.011 | 0.422 | 0.035 | Purinergic P2Y2 antagonist | 0.032 0.025 DBMET00102 0.035 0.022 DBMET03597 | DBMET03597 | |
| 0.102 | 0.524 | 0.42 | Antiinflammatory | 0.42 0.127 DBMET00102 0.389 0.146 DBMET03597 | DBMET00102 | |
| 0.005 | 0.44 | 0.02 | Adenosine A3 receptor agonist | 0.02 0.009 DBMET00102 0.02 0.009 DBMET03597 | DBMET03597 | |
| 0.054 | 0.497 | 0.347 | Antithrombotic | 0.312 0.081 DBMET00102 0.347 0.066 DBMET03597 | DBMET03597 | |
| 0.004 | 0.447 | 0.029 | Purinergic P2X agonist | 0.029 0.018 DBMET00102 0.029 0.018 DBMET03597 | DBMET03597 | |
| 0.024 | 0.536 | 0.155 | Free radical scavenger | 0.151 0.143 DBMET00102 0.155 0.139 DBMET03597 | DBMET03597 | |
| 0.023 | 0.546 | 0.237 | Platelet antagonist | 0.205 0.097 DBMET00102 0.237 0.078 DBMET03597 | DBMET03597 | |
| 0.077 | 0.613 | 0.217 | Interleukin 2 agonist | 0.21 0.173 DBMET00102 0.217 0.161 DBMET03597 | DBMET03597 | |
| 0.02 | 0.569 | 0.063 | Adenine nucleotide translocase inhibitor | 0.063 0.023 DBMET00102 0.063 0.023 DBMET03597 | DBMET03597 | |
| 0.004 | 0.554 | 0.016 | Adenosine A2b receptor agonist | 0.016 0.009 DBMET00102 0.016 0.008 DBMET03597 | DBMET03597 | |
| 0.011 | 0.579 | 0.131 | Bronchodilator | 0.131 0.039 DBMET00101 | DBMET00101 | |
| 0.044 | 0.663 | 0.349 | Cyclophilin D inhibitor | 0.314 0.15 DBMET00102 0.349 0.123 DBMET03597 | DBMET03597 | |
| 0.005 | 0.635 | 0.055 | Selectin antagonist | 0.055 0.054 DBMET03597 | DBMET03597 | |
| 0.008 | 0.64 | 0.054 | Protein 50S ribosomal subunit inhibitor | 0.054 0.035 DBMET00102 0.052 0.038 DBMET03597 | DBMET00102 | |
| 0.003 | 0.665 | 0.038 | Adenosine A1 receptor agonist | 0.037 0.008 DBMET00102 0.038 0.008 DBMET03597 | DBMET03597 | |
| 0.024 | 0.699 | 0.361 | Immunosuppressant | 0.361 0.081 DBMET00102 0.353 0.085 DBMET03597 | DBMET00102 | |
| 0.066 | 0.753 | 0.321 | Peptidyltransferase inhibitor | 0.32 0.018 DBMET00102 0.321 0.018 DBMET03597 | DBMET03597 | |
| 0.029 | 0.722 | 0.221 | Hypoglycemic | 0.21 0.103 DBMET00102 0.221 0.095 DBMET03597 | DBMET03597 | |
| 0.019 | 0.72 | 0.207 | DNA polymerase I inhibitor | 0.207 0.026 DBMET00102 0.207 0.026 DBMET03597 | DBMET03597 | |
| 0.013 | 0.725 | 0.241 | Angiogenesis stimulant | 0.241 0.074 DBMET00102 0.241 0.074 DBMET03597 | DBMET03597 | |
| 0.008 | 0.733 | 0.099 | Uric acid excretion stimulant | 0.099 0.054 DBMET00102 0.093 0.061 DBMET03597 | DBMET00102 | |
| 0.001 | 0.765 | 0.014 | Purinergic P2 agonist | 0.014 0.011 DBMET00102 0.014 0.011 DBMET03597 | DBMET03597 | |
| 0.001 | 0.765 | 0.014 | Purinergic receptor agonist | 0.014 0.011 DBMET00102 0.014 0.011 DBMET03597 | DBMET03597 | |
| 0.001 | 0.77 | 0.011 | Purinergic P2Y agonist | 0.011 0.01 DBMET03597 | DBMET03597 | |
| 0.022 | 0.808 | 0.17 | Hepatoprotectant | 0.17 0.089 DBMET00102 0.167 0.092 DBMET03597 | DBMET00102 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |